Gearing up for its national multicenter clinical trial of the ReWalk exoskeleton, the US Department of Veterans Affairs (VA) has purchased an additional 20 ReWalk Personal 6.0 Systems from ReWalk Robotics Ltd.

The reportedly first-ever trial performed in the United States to examine the use of the ReWalk exoskeleton will include 160 participants from across the country, and will involve six VA medical centers in its first phase across California, Florida, Massachusetts, Texas, and Virginia.

The participating VA medical centers have received ReWalk Personal Systems to begin their training. Eligible participants in the trial will be enrolled later this year, according to a media release from ReWalk Robotics.

“The purchase of 20 additional systems is a critical acquisition for this groundbreaking clinical trial,” says ReWalk CEO Larry Jasinski, in the release.

“The initiation of the study across these six VA Medical Centers will provide many veterans access to training with exoskeleton technology. We continue to work closely with the VA and offer our support as the trial gets underway,” he adds.

For more information, visit ReWalk Robotics Ltd.

[Source(s): ReWalk Robotics Ltd, PR Newswire]